About

Haobo Li, PhD

 

Contact

Room 3400, 185 Cambridge Street, Boston, MA 02114. Tel: 1-617-800-7960. Email: haobo.li [AT] mgh.harvard.edu or drhaoboli[AT]gmail.com

Academic Appointment

2019- Instructor in Medicine, Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School

2017-2019 Research Fellow, Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School

Education

The University of Hong Kong (PhD, Advisor: Dr. ZY Xia and Prof. MG Irwin); South China Agricultural University (MSc, Advisor: Prof. XB Wen and Bsc, Advisor: Prof. JY Ma)

Hornor

AHA Career Development Award (2021-2023); Melvin L. Marcus Early Career Investigator Award Finalist (2020); BCVS Abstract Travel Award (2019); Faculty Research Output Award (2018); AHA Postdoctoral Fellowship (2017-2019); Fellow of Global Young Scientists Summit (2016); YS and Christabel Lung Postgraduate Scholarship (2015); Graduate Student Scientist Award (2015)...

Professional Service

Member: American Heart Association (2014-); American Society for Pharmacology & Experimental Therapeutics (2013-); International Society of Heart Research (2016-); International Anesthesia Research Society (2014-); American Diabetes Association (2018-).

Reviewer: JACC; JAMA Surg; Ann Intern Med; Cell Death Dis; Br J Pharmacol; JAHA; BBA Mol Basis Dis; Br J Anaesth; Clin Sci; Aging-US; Sci Rep; PLoS One; J Cell Mol Med; Oxid Med Cell Longev; Front Physiol; Cell Physiol Biochem; Appl Physiol Nutr Metab; Am J Physiol Heart Circ Physiol;Am J Physiol Cell Physiol; J Appl Physiol; Neuroscience; J Biochem Mol Toxicol; Biochem J; Biomed Pharmacother; J Diabetes Res; Horm Metab Res; J Therm Biol; J Diabetes; Physiol Genomics; Gene; Eur J Pharmacol; Biosci Rep; Neural Regen Res; Biomed Rep; J Biochem Mol Toxicol; Mol Med Rep; Br J Med Med Res.

Editor: Oxid Med Cell Longev (Leading guest editor, 2017, 2018); Int J Mol Sci (Guest editor, 2017)

Grant reviewer: Swiss National Science Foundation (2015-2019)

Selected Publication

  1. Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, To S, Li G, Yeri A, Rodosthenous R, Silverman MG, Das S, Ambardekar AV, Bristow MR, Gonzalez-Rosa JM, Rosenzweig A. lncExACT1 and DCHS2 regulate physiological and pathological cardiac growth. Circulation, 2022,145:1234-37. (Published with an editorial)

  2. Li H, Hastings M, Rhee J, Trager L, Roh J, Rosenzweig A. Targeting age-related pathways in heart failure. Circ Res. 2020,126:533-51

  3. Li H, Yao W, Liu Z, Xu A, Huang Y, Ma XL, Irwin MG, Xia Z. Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in Diabetic Rats. Diabetes 2016, 65(4):942-55. (Published with an commontary)

  4. Li H, Yao W, Irwin MG, Wang T, Wang S, Zhang L, Xia Z. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radic Biol Med 2015, 84:311-21.

  5. Li H, Liu Z, Wang J, Wong GT, Cheung CW, Zhang L, Chen C, Xia Z, Irwin MG. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol 2013, 12,133. (Highly accessed)

Full list of publication on pubmed: https://www.ncbi.nlm.nih.gov/myncbi/haobo.li.1/bibliography/54248051/public/